Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. | Director | Common Shares | 79.1K | $836K | $10.57 | Jul 23, 2024 | Direct |
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct | ||
PRA Health Sciences, Inc. | Director | Common Stock | 0 | $169.75 | Jul 1, 2021 | Direct |